InnoMedica
worldleaksThis record tracks a ransomware attack claimed by the worldleaks group against InnoMedica. It collects the publicly disclosed attack details — sector, location and timeline — as published on the operator's leak site and indexed by Breach House.
Window Zero
EXPOSURE GAPWindow Zero is the time the breach stayed in the open before anyone said so — the gap between when the attack was first discovered on the operator's leak site (t1) and when it was publicly disclosed (t2). The wider this window, the longer victims, staff and customers were exposed with no warning.
Attack Summary
[AI generated] InnoMedica is a Swiss-based biopharmaceutical firm focused on the development of tailored treatments for serious conditions such as cancer and neurological disorders. Its primary product, Talidox, is a nanomedical cancer drug that targets only tumor cells. InnoMedica's research is focused towards the technological advancements in medicine to provide more effective treatments.
Leak Screenshots
SAMPLEProof-of-breach screenshots the operator posted from the stolen data. Previews are redacted and locked — the originals are available on HaveIBeenRansom.